Skip to Content
Merck
All Photos(1)

Key Documents

20832-U

Supelco

ORBO 402 Tenax® TA specially treated (35/60), 100/50 mg

W,W,W separators, O.D. × L 8 mm × 100 mm, pkg of 50 ea

Synonym(s):

ORBO Tenax® TA

Sign Into View Organizational & Contract Pricing

Select a Size

50 EA
CZK 12,300.00

CZK 12,300.00


Please contact Customer Service for Availability

Request a Bulk Order

Select a Size

Change View
50 EA
CZK 12,300.00

About This Item

UNSPSC Code:
12190000
NACRES:
NB.24

CZK 12,300.00


Please contact Customer Service for Availability

Request a Bulk Order

material

W,W,W separators

Quality Level

Agency

NIOSH 2507,2545,7905
OSHA 43

product line

ORBO

composition

Bed A, 100 mg
Bed B, 50 mg

packaging

pkg of 50 ea

manufacturer/tradename

ORBO 402

technique(s)

active air sampling: suitable

O.D. × L

8 mm × 100 mm

matrix

Tenax TA (specially treated)

particle size

35-60 mesh

application(s)

air monitoring
environmental
industrial hygiene

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
20029-U29539-U29741-U
material

W,W,W separators

material

RC,GFF,F,F (specially cleaned) separators

material

glass TD tube

material

stainless steel TD tube

agency

NIOSH 2507,2545,7905, OSHA 43

agency

-

agency

EPA TO-1,IP-1B

agency

EPA TO-1,IP-1B

technique(s)

active air sampling: suitable

technique(s)

active air sampling: suitable

technique(s)

active air sampling: suitable

technique(s)

active air sampling: suitable

product line

ORBO

product line

Amberlite, ORBO

product line

-

product line

-

packaging

pkg of 50 ea

packaging

pkg of 10 ea

packaging

pkg of 10 ea

packaging

pkg of 10 ea

General description

ORBO 402 Tenax® TA specially treated (35/60), 100/50 mg is a glass tube containing dual-layered beds of the same selective adsorbent separated by glass wool or foam for gas and vapor sampling. This construction of the tube allows for any sample breakthrough to be captured in the smaller backup bed.

It is compatible with gas chromatography-mass spectrometry (GC-MS) equipment and is commonly used for breath analysis applications. [1]

Application

ORBO 402 Tenax® TA specially treated (35/60), 100/50 mg has been used as an absorbent for the collection of air samples to determine benzene at trace levels in the environment during the GC/MS analysis. [2]

Legal Information

ORBO is a trademark of Sigma-Aldrich Co. LLC
Tenax is a registered trademark of Buchem B.V.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Low-cost desorption unit coupled with a gold nanoparticles gas sensors array for the analysis of volatile organic compounds emitted from the exhaled breath (gastric cancer and control samples.
Cristhian Manuel D, et al.
Microelectronic Engineering, 237, 111483-111483 (2021)
Determination of benzene at trace levels in air by a novel method based on solid-phase microextraction gas chromatography/mass spectrometry.
Alessandro S, et al.
Rapid Communications in Mass Spectrometry, 15, 2404-2408 (2001)
H Stalsberg et al.
Virchows Archiv. A, Pathological anatomy and histopathology, 414(5), 415-422 (1989-01-01)
The autopsies of 12 victims from two snow avalanches in North-Norway are reported. Supportive evidence from non-autopsied and surviving victims is included. Consistent autopsy findings were prominent lung oedema, moderate cerebral oedema, extreme contraction of the left ventricle, petechiae in
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
A Ørbo et al.
BJOG : an international journal of obstetrics and gynaecology, 123(9), 1512-1519 (2015-12-03)
To investigate relapse rates after the successful treatment of patients with non-atypical endometrial hyperplasia who were randomised to either a levonorgestrel-impregnated intrauterine system (LNG-IUS; Mirena(®) ) or two regimens of oral medroxyprogesterone acetate (MPA) after primary histological response. A multicentre

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service